Phase II trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC)Rafal Wierzbicki, Adnan Ezzat, Abdel‐Wahab A. Abdel‐Warith et al.|Annals of Oncology|1994Cited by 14